SHBG and breast cancer: We also evaluated potential variation in the risk estimates for free testosterone by adjusting in different models for progesterone, total testosterone, estradiol, and SHBG, and by excluding breast cancer cases diagnosed within 2 years after blood collection (n = 35), and all the risk estimates remained very similar (data not shown).